Crohn's disease and the SAPHO syndrome during treatment with infliximab: A case report and review of literature;Maladie de Crohn et syndrome SAPHO, au cours d'un traitement à l'infliximab: Cas clinique et revue de la littérature

Gastroenterologie Clinique et Biologique

Volumn 31, Issue 6-7, 2007, Pages 607-610

  Van Den Eynde, Marc ^a   Lecluyse, Katrien ^a   Chioccioli, Cristiano ^a   Brouckaert, Marie ^a   Caussin, Emmanuelle ^a   Lammens, Pierre ^a  

^a Clinique Saint Jean   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INFLIXIMAB;

ADULT; ARTICLE; ASEPTIC SPONDYLITIS; CASE REPORT; CROHN DISEASE; FEMALE; HUMAN; ILEUM; LITERATURE; OBSERVATIONAL STUDY; PUSTULOSIS PALMOPLANTARIS; SAPHO SYNDROME; SPONDYLITIS;

EID: 34447623977     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0399-8320(07)89438-3     Document Type: Article

References (18)

1. Kahn MF, Bouchon JP, Chamot AM, Palazzo E. Entérocolopathies chroniques et syndrome SAPHO ; 8 observations. Rev Rhum Mal Osteoartic 1992;59:91-4.
2. Dharancy S, Talbodec N, Asselah T, Hachulla E, Delaporte E, Cortot A, et al. Le syndrome SAPHO, une manifestation extra-digestive rare de la maladie de Crohn. Gastroenterol Clin Biol 1998;22:240-3.
3. Schilling F, Marker-Hermann E. Chronic recurrent multifocal osteomyelitis in association with chronic inflammatory bowel disease: enteropathic CRMO. Z Rheumatol 2003;62:527-38.
4. Schilling F, Kessler S. SAPHO syndrome: clinico-rheumatologic and radiologic differentiation and classification of a patient sample of 86 cases. Z Rheumatol 2000;59:1-28.
5. Hayem G, Bouchaud-Chabod A, Benali K, Roux S, Palazzo E, Silberman-Hoffman O, et al. SAPHO syndrome: a long-term follow-up study of 120 cases. Semin Arthritis Rheum 2000;29:159-71.
6. Kahn MF, Khan MA. The SAPHO syndrome. Baillières Clin Rheumatol 1994;8:333-62.
7. Chamot AM, Benhamou C, Kahn MF, Beraneck L, Prost A. Le syndrome acné putulose hyperostose ostéite (SAPHO). Résultats d'une enquête nationale ; 85 observations. Rev Rhum Mal Osteoartic 1987;54:187-96.
8. Kahn MF. Actualité du syndrome SAPHO. Presse Med 1995;24:338-40.
9. Wagner AD, Andresen J, Jendro MC, Hulsemann JL, Zeidler H. Sustained response to tumor necrosis factor alpha-blocking agents in two patients with SAPHO syndrome. Arthritis Rheum 2002;46:1965-8.
10. Massara A, Cavazzini PL, Trotta F. In SAPHO syndrome anti-TNF-alpha therapy may induce persistent amelioration of osteoarticular complaints, but may exacerbate cutaneous manifestations. Rheumatology (Oxford) 2006;45:730-3.
11. Dereure O, Guillot B, Jorgensen C, Cohen JD, Combes B, Guilhou JJ. Psoriatic lesions induced by antitumour necrosis factor alpha treatment : two cases. Br J Dermatol 2004;151: 506-7.
12. Starmans-Kool M, Peeters H, Houben L. Pustular skin lesions in patients treated with infliximab: report of two cases. Rheumatol Int 2005;25: 550-2
13. Kary S, Worm M, Audring H, Huscher D, Renelt M, Sörensen H, et al. New onset or exacerbation of psoriatic skin lesions in patients with definite rheumatoid arthritis receiving tumour necrosis factor alpha antagonists. Ann Rheum Dis 2006;65:405-7.
14. Adams DR, Buckel T, Sceppa JA. Infliximab associated new-onset psoriasis. J Drugs Dermatol 2006;5:178-9.
15. Leung DY, Travers JB, Giorno R, Norris DA, Skinner R, Aelion J, et al. Evidence for a streptococcal superantigen-driven process in acute guttate psoriasis. J Clin Invest 1995;96:2106-12.
16. Owen CM, Chalmers RJ, O'Sullivan T, Griffiths CE. Antistreptococcal interventions for guttate and chronic plaque psoriasis. Cochrane Database Syst Rev 2000;2:CD001976.
17. Amital H, Applbaum YH, Aamar S, Daniel N, Rubinow A. SAPHO syndrome treated with pamidronate: an open-label study of 10 patients. Rheumatology (Oxford) 2004;43:658-61.
18. Schilling F, Wagner AD. Azithromycin: The antiinflammatory and local immunomodulatory effects in chronic recurrent multifocal osteomyelitis - a preliminary communication. Z Rheumatol 2000;59:352-3.